Identification of a novel neuron-specific surface antigen in the developing nervous system, by monoclonal antibody 4C5.

Monoclonal antibody 4C5 was obtained after immunization of Balb/c mice with a crude membrane preparation derived from the brains of 15-day-old rat embryos. As revealed by immunocytochemistry on primary cell cultures from embryonic rat brain, it was shown that the antigen recognized by monoclonal antibody 4C5 (4C5 antigen) is localized on the cell surface of the neurons. Preliminary biochemical characterization showed that it is a peripheral protein with a molecular weight of 94,000. The 4C5 antigen does not appear to be linked with other polypeptides by S--S bonds and contains few or no disulphide intramolecular bridges. N-Glycanase digestion indicated that the protein is probably not glycosylated. Monoclonal antibody 4C5 crossreacts with membrane fractions from rat, rabbit, pig and human developing brain. It was shown by immunohistochemistry that the 4C5 antigen is widely distributed in the embryonic and adult rat brain. In the peripheral nervous system 4C5 immunoreactivity was present in dorsal root ganglion neurons. Immunoblotting and immunohistochemistry on dissociated cells from rat brain and on tissue sections of brain and dorsal root ganglia revealed an age-dependent decline in the expression of the epitope recognized by monoclonal antibody 4C5, in the central and peripheral nervous system. In particular, intense 4C5 immunoreactivity was observed during the embryonic and early postnatal ages. By the second postnatal week, expression of the protein was greatly reduced, becoming very weak at later stages of development and in the adult animal. In PC12 cell cultures, expression of the 4C5 antigen was intense in proliferating cells while being greatly reduced after nerve growth factor induced differentiation of these cells. The increased expression of the 4C5 antigen in proliferating PC12 cells and the prominent presence of this molecule during a time of neuronal migration suggest that it is involved in these developmental events.

Neuron- and myelin-specific monoclonal antibodies recognizing cell-surface antigens of the central and peripheral nervous system.

Immunohistochemical screening of monoclonal antibodies raised against Triton X-114-treated synaptic membranes revealed two monoclonal antibodies, namely BM88 and BM72, with characteristic binding specificities in the central and peripheral nervous systems of the pig. Monoclonal antibody BM88 was exclusively associated with neuronal elements while BM72 was myelin-specific. Thus, in the central nervous system, immunostaining with BM88 was observed throughout the gray matter of all regions of the forebrain and spinal cord tested. In the peripheral nervous system, BM88 strongly labelled the perikarya and processes of dorsal root ganglion neurons as well as the myelinated and unmyelinated neuronal processes of the dorsal roots; BM88 immunoreactivity was also detected in neuronal cell bodies and fibres of the enteric ganglia. In addition, BM88 immunolabelled the cell-surface of cultured neurons derived from brain. In mixed cultures the staining was uniformly distributed on the perikarya and along the neurites of these cells. However, in neuron-enriched cultures where 95% of the cells were immunochemically identified as neurons, the staining of the neuronal surface membrane was patchy. This phenomenon was independent of days in culture and suggested that the distribution of the BM88 antigen on the cell surface of neurons may be regulated by neuron glia interactions. By Western blotting, the antigen recognized by BM88 in brain membrane fractions which had undergone reducing sodium dodecyl sulphate/polyacrylamide gel electrophoresis was shown to be a 22,000 mol. wt polypeptide. When extracted with Triton X-114 this polypeptide partitioned into the detergent-rich phase, a property typical of an amphipathic membrane protein. In non-reducing conditions BM88 bound to a band with a molecular weight of 43,000. These results show that the BM88 antigen is composed of two polypeptide chains of equal molecular weight linked by disulphide bridges. Monoclonal antibody BM72 recognized a myelin-associated antigen in the central and peripheral nervous system. Immunohistochemical evidence suggested a cell-surface location for this antigen. By solid phase radioimmunoassay, monoclonal antibody BM88 was shown to cross-react with brain membrane fractions from pig, rabbit and rat while BM72 recognized only a pig membrane antigen. Both monoclonal antibodies BM88 and BM72 may be used as specific cellular markers in the nervous system.

Dissociation between testicular morphogenesis and functional differentiation of Leydig cells.

The aim of the study was to determine whether Leydig cells differentiate in vitro in gonads in which the formation of seminiferous cords is prevented by culture in a medium containing fetal calf serum. Appearance of 3 beta-hydroxysteroid dehydrogenase-positive cells and release of testosterone in the medium occurred at the same age irrespective of whether or not the gonads developed seminiferous cords. It is concluded therefore that testicular morphogenesis with the formation of seminiferous cords is not a prerequisite for the emergence and functional differentiation of Leydig cells.

Migration behavior of rodent granule neurons in the presence of antibody to the 4C5 antigen.

We have reported the production of monoclonal antibody 4C5, which recognizes a cell surface antigen, the 4C5 antigen, involved in granule cell migration processes. In the present study, we investigated in a more precise manner the role of the 4C5 antigen in the different types of granule cell migrations that take place during cerebellar development. When cerebellar explant cultures derived from 10-day-old rats were performed for 2 days in the presence of monoclonal antibody 4C5, vertical granule cell migration, occurring in the presence of glia, was not significantly inhibited. In contrast, when monoclonal antibody 4C5 was included in the medium of microexplant cultures derived from 4-day-old mice and maintained for 4 days in vitro, granule cell migrations that occurred both parallel and perpendicular to the neurite bundles that were free of glia were inhibited. Moreover, a stronger inhibitory effect of the antibody was observed on migration perpendicular to the neurite bundles compared with the parallel type of migration. Our results indicate that the 4C5 antigen differentially affects the different developmental stages and types of granule cell migration during rodent cerebellar development.

Purification and characterization of neuron-specific surface antigen defined by monoclonal antibody BM88.

Monoclonal antibody BM88 recognizes a neurospecific surface antigen in the CNS and the PNS. In the present study, the antigen recognized by BM88 was immunopurified from pig brain and shown to be a 22-kDa polypeptide by reducing sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Under nonreducing conditions a protein of 40 kDa was obtained, a result indicating that the antigen is composed of two polypeptide chains of equal molecular weight linked by disulfide bridges. Gel filtration of the purified antigen in the presence of Emulphogene suggested that it may be either a monomeric or a dimeric protein. However, in the presence of Triton X-100 a monomeric structure was implied. N-Glycanase digestion indicated that the protein is probably not glycosylated. The purified antigen was characterized as an integral membrane protein by hydrophobic chromatography and phase-separation experiments with Triton X-114. The antigen, or at least the antibody binding region of the molecule, is very susceptible to protease attack, as judged by protease digestion experiments on brain membranes. By using very low concentrations of papain combined with short incubation times, the antigen was converted to a 16.3-kDa membrane-associated polypeptide as assessed by immunoblotting. This polypeptide contained the BM88 binding epitope. Soluble BM88 immunoreactive polypeptides were not obtained. Bacillus cereus phospholipase C was also unable to solubilize the antigen from the membrane. Our results suggest that the molecule, possessing at least one small extramembranous domain, is attached to the membrane via a polypeptide chain.

Expression of the 4C5 antigen during development and after injury of the rat sciatic nerve.

We have previously reported the production of monoclonal antibody 4C5 that recognizes a cell surface neuron specific antigen, the 4C5 antigen (Thomaidou and Patsavoudi: Neuroscience 53:813-827, 1993). Antibody perturbation experiments have suggested that the 4C5 antigen is involved in granule cell migration processes in vitro (Thomaidou et al: J Neurochem 64:1937-1944, 1995). In the present study, we have used monoclonal antibody 4C5 to investigate the cellular distribution and the expression of the corresponding antigen during development, and after injury of the rat sciatic nerve. Immunocytochemistry revealed presence of the protein both in myelin and non-myelin forming Schwann cells. Western blot analysis showed that monoclonal antibody 4C5 recognizes the same 94 kdalton polypeptide in the sciatic nerve as in the brain. Immunocytochemical analysis revealed an age-dependent decline of the 4C5 antigen expression. Moreover, following adult sciatic nerve crush, 4C5 immunoreactivity becomes intense in Schwann cells of the distal segment, as early as 4 days after injury and remains at relatively high levels up to 2 weeks after the crush. By the 3rd week, 4C5 immunoreactivity is greatly reduced, and by the 4th week it is hardly detectable. Our results concerning the cellular localization and temporal expression of the 4C5 antigen during development and after injury of the rat sciatic nerve, suggest that it may participate in Schwann cell migrations that occur during such processes.

Developmental expression and functional characterization of the 4C5 antigen in the postnatal cerebellar cortex.

The monoclonal antibody 4C5 recognizes a neuron-specific surface antigen (4C5 antigen) in the CNS and PNS of the rat. In the present study we investigated the expression of 4C5 antigen in the developing cerebellum of the rat and the functional role of this molecule during cerebellar morphogenesis. Immunoblotting and immunohistochemistry in sections of cerebellar cortex revealed an age-dependent decrease in the expression of the 4C5 antigen. In cerebellar primary cell cultures, 4C5 immunoreactivity was detected both on granule and on Purkinje neurons. Granule cell migration was inhibited in cerebellar explants derived from 8-day-old rats and cultured for 2 days in the presence of antibodies against the 4C5 antigen. Electron microscope immunocytochemistry revealed that in 8-day-old rat cerebellum, 4C5 immunoreactivity was localized on the cell bodies of granule neurons in the external and internal granular layers and on parallel fibers in the developing molecular layer as well as at contact sites between these cellular elements. It was not detected on Bergmann glia. These results suggest strongly that the 4C5 antigen is involved in granule cell migration during cerebellar development, possibly via neuron-neuron interactions.

Initial phases of the rat testis differentiation in vitro.

Rat gonadal primordia with their supporting mesonephroi were explanted in vitro at the undifferentiated stage (12 days 16 h after fertilization), at the outset of testicular differentiation (13 days 9 h) or when already containing seminiferous cords. The younger foetuses were sexed with the sex chromatin test in the amniotic membrane. The basal medium was CMRL 1066 and the culture period, 1 to 4 days. Testicular differentiation resulted from the appearance of large clear cells, the primordial Sertoli cells, and from their aggregation into seminiferous cords. Addition of 15% foetal calf serum to the medium prevented the differentiation of seminiferous cords, but large clear cells appeared. In testes from 14- or 15-day-old foetuses, the seminiferous cords disintegrated under the influence of serum. The serum did not prevent the differentiation of Sertoli cells, but impaired organogenesis or maintenance of the early seminiferous cords. The results support previous histological observations on the initial stages of testicular differentiation.

Characterization and localization of the BM88 antigen in the developing and adult rat brain.

Monoclonal antibody BM88 identifies a neuron-specific antigen (BM88 antigen) present in the central and peripheral nervous system of the pig (Patsavoudi et al.: Neuroscience 30:463-478, 1989; J Neurochem 56:782-788, 1991). We have previously shown that the antigen is also expressed by cultured neurons derived from newborn rat brain. In the present study we have used the monoclonal antibody BM88 and a specific polyclonal antibody in order to identify the nature of the cross-reactive antigen in rat brain and to investigate its expression and cellular localization in the developing and adult rat nervous system. Western blot analysis and immunocytochemistry revealed that the rat BM88 antigen displays very similar biochemical properties with its porcine homologue. It is a neuron-specific integral membrane protein, apparently not glycosylated, consisting of two 23 kD polypeptide chains. Immunoperoxidase staining demonstrated that the BM88 antigen is widely distributed in the brain of 19-day-old rat embryos. At this stage, immunoreactivity was particularly prominent in differentiated cellular areas and developing fiber tracts of the embryonic rat brain, but was also present in the neuroepithelium. A similar wide distribution of the BM88 antigen was observed in the adult rat brain. Here, immunoreactivity was detected in the neuropil and neuronal perikarya. Immunocytochemical analysis of the expression of the BM88 antigen during postnatal development of the cerebellar cortex showed that this molecule is particularly concentrated in the Purkinje cells between postnatal days 10 to 15; their somata and developing dendrites were distinctly immunopositive during this period. An age-dependent increase in the expression of the BM88 antigen both in brain and in the cerebellum was noted. Electron microscopy confirmed the presence of the BM88 reaction product within the perikarya, axons and dendrites of labeled neurons in the adult brain. The BM88 reaction product was preferentially associated with the limiting membrane of mitochondria, endoplasmic reticulum and small electron-lucent vesicles, but was also present in the plasma membrane, especially at the level of synaptic densities. Our results show that the BM88 antigen participates in an activity common to all or most neurons, and demonstrate that the expression of this antigen is elevated upon neuronal differentiation and maturation.

Upgrading the biomedical engineering undergraduate curriculum based on current trends in higher education.

This paper presents the reforming of the curriculum of the Department of Medical Instrumentation Technology at the Technological Educational Institution of Athens (TEI-A), as inspired by current trends in higher education. The reforming is taking place in the framework of the "Upgrading of Undergraduate Curricula of TEI-A" project The project-funded upgrading focuses on a core of eight laboratory sectors, with particular emphasis placed on student-centered learning, taking advantage of computer-enhanced educational environment. The existing and proposed curricula are compared. The student workload in the proposed curriculum is reduced, while maintaining an extensive set of basic and applied knowledge related to biomedical engineering. The overall aim is to provide a curriculum that will help in developing multi-skilled individuals that can relate to the demands of this field within a dynamic social and economical environment.

The BM88 antigen, a novel neuron-specific molecule, enhances the differentiation of mouse neuroblastoma cells.

The BM88 antigen is a neuron-specific molecule widely distributed in the mammalian nervous system. It is a 22-kDa, apparently not glycosylated, integral membrane protein, which appears early during brain development and remains at high levels in the mature animal. Here, we describe the cDNA cloning of the porcine BM88 antigen and present evidence that this protein is involved in neuroblastoma cell differentiation. The deduced protein is a novel molecule consisting of 140 amino acids and bears a putative transmembrane domain at the COOH-terminal region. The mRNA of this protein is expressed only in neural tissues, where it is restricted to neurons. Stably transfected Neuro-2a cells overexpressing the BM88 antigen exhibited a significant change in morphology, reflected by enhanced process outgrowth, and a slower rate of division. Moreover, in the presence of differentiation agents, such as sucrose and retinoic acid, an accelerated differentiation of the transfected Neuro-2a cells was observed. Especially in the presence of sucrose, the consequent overexpression of the BM88 antigen in the transfected cells resulted in their enhanced morphological differentiation accompanied by the induction of neurofilament protein expression. Our results suggest that the BM88 antigen plays a role in the differentiation of neuroblastoma cells.

Wasting, ischemia, and lymphoid abnormalities in mice expressing T cell-targeted human tumor necrosis factor transgenes.

To evaluate the biologic potential of T cell-specific TNF production in vivo, we have generated transgenic mice constitutively expressing TNF in their T cell compartment. This was achieved by placing a wild-type or a 3'-UTR modified fragment of the human TNF gene under the influence of the T cell-specific, locus control region of the human CD2 gene. Transgenic mice that express human TNF mRNA in T cells develop marked histologic and cellular changes locally in their lymphoid organs and a lethal wasting syndrome associated with widespread vascular thrombosis and tissue necrosis. The extent of pathologic changes and their time of onset appear to reflect levels of transgene expression. Thus, transgenic lines that express the transgene at high levels show both lymphoid organ and systemic abnormalities with wasting. In one transgenic line, mice express lower levels of the transgene and develop normally despite pronounced local lymphoid organ defects, confirming in vivo, the differential potential of localized and systemic TNF action. All pathologic changes could be neutralized by the administration of mAb specific for human TNF. These results demonstrate the important role of T cell-specific TNF production in the development of specific pathology and provide a means by which to evaluate the role of TNF in thymocyte development. Transgenic mice that express TNF constitutively in the T cell compartment offer a unique in vivo system by which to analyze the molecular character of systemic vs contact-dependent and paracrine modes of TNF action. Furthermore, given the species-specific nature of the mouse p75 TNF receptor, it is assumed that the pathology induced by human TNF in these transgenic mice is associated exclusively with p55 TNF receptor signaling. Conceivably, the differential contribution of each of the two TNF receptors in thymus development and TNF-mediated disease can be assessed by comparison of the biologic potential of human vs mouse TNF in the transgenic system developed.